Study of STSP-0902 for low sperm count or motility
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study tests an investigational drug called STSP-0902, given as multiple doses, to see if it can improve sperm count and movement in men with low sperm count or reduced sperm motility. It aims to help men who have no known cause for their infertility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man between 18 and 50 years old.
- You must have low sperm count or reduced sperm movement (or both), confirmed by two semen tests.
- You must not have a known cause for your low sperm count, such as an infection, injury, surgery, genetic condition, or certain hormonal problems.
- Your follicle-stimulating hormone (FSH) level must be below 8 IU/L.
- You must agree to use effective contraception (like condoms) and not plan pregnancy or donate sperm during the study and for 1 month after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called STSP-0902 to see if it is safe in healthy men. It may help men with low sperm count or poor sperm movement, but the main goal is to check for side effects.
This trial tests if a supplement made from Tribulus Terrestris (a plant) can help men with low sperm count (oligospermia) improve their fertility. It may be an option for men who are considering hormone treatments.
This study tests a new method for preparing sperm to help with fertility treatments. It is for men who can provide a semen sample and have no active infections or history of certain viruses.
This study tests an experimental medicine called MediReg® for men with severe infertility who have not been able to conceive. It aims to see if the drug is safe and can improve sperm quality, possibly offering a new option for men who have not had success with other treatments.
This trial studies whether gonadotropin therapy (hormones that stimulate sperm production) can help men with low testosterone and very low sperm count. It may be useful if you have been diagnosed with non-obstructive azoospermia and have not had recent surgery or hormone treatment.
This study tests two medicines—isotretinoin and human chorionic gonadotropin (hCG)—to see if they can improve sperm production in men with low sperm counts or no sperm due to certain causes. It might help if you haven't responded to other treatments before.
Hear when a new Oligozoospermia and/or Asthenozoospermia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.